Dr. Billington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Minneapolis VAMC Metabolic Section 111g
One Veterans Drive
Minneapolis, MN 55417Phone+1 612-725-2000Fax+1 612-676-5036
Summary
- Dr. Charles Billington is an experienced endocrinologist based in Minneapolis, MN, with multiple subspecialties including Diabetes, Gonad Disorders & Reproductive, Lipid Metabolism, and Obesity. He completed his medical education at the University of Kansas School of Medicine in 1978, later finishing his residency in Internal Medicine and fellowship in Endocrinology, Diabetes, and Metabolism at the University of Minnesota. Dr. Billington is also a highly published physician, with noteworthy research in diverse areas such as pharmacotherapy-based obesity care, bio-electronic devices for glycemic control, prevalence of thyroid incidentalomas, and obesity prevention in the workforce. His research has been widely recognized, often cited by other publications.
Education & Training
- University of MinnesotaFellowship, Endocrinology, Diabetes, and Metabolism, 1983
- University of MinnesotaResidency, Internal Medicine, 1978 - 1981
- University of Kansas School of MedicineClass of 1978
Certifications & Licensure
- MN State Medical License 1981 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 89 citationsTwo-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge TrialCaroline M. Apovian, Sajani Shah, Bruce M. Wolfe, Sayeed Ikramuddin, Christopher J. Miller
Obesity Surgery. 2017-01-01 - 61 citationsVagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus.Scott A. Shikora, James Toouli, Miguel F. Herrera, Baard Kulseng, Henryk Zulewski
Journal of Obesity. 2013-07-30 - 123 citationsIntra-abdominal vagal blocking (VBLOC therapy): Clinical results with a new implantable medical deviceMichael Camilleri, Jim Toouli, Miguel F. Herrera, Bård Kulseng, Lilian Kow
Surgery. 2008-06-01
Press Mentions
- ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScienceOctober 25th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: